North America capnography devices market was valued at $196.8 million in 2025 and is projected to reach $296.4 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026–2035). Capnography devices, which provide continuous monitoring of end-tidal CO? (EtCO?) and respiratory status, are increasingly critical across operating rooms, intensive care units (ICUs), emergency departments, and procedural sedation settings. The market encompasses mainstream and sidestream capnography systems, standalone monitors, and integrated multiparameter patient monitoring solutions. Market growth is driven by the rising prevalence of respiratory and cardiovascular diseases, increasing surgical volumes, and the expanding use of capnography for patient safety during anesthesia, sedation, and mechanical ventilation. Strong clinical guidelines emphasizing continuous CO? monitoring, coupled with widespread adoption in emergency medicine and critical care, are accelerating uptake across the U.S. and Canada. Additional momentum comes from technological advancements, including compact portable devices, wireless connectivity, AI-assisted alerts, and integration with hospital information systems to support real-time clinical decision-making.
Browse the full report description of “North American capnography devices Market Size, Share & Trends Analysis Report by Product Type (Handheld, Standalone, Multiparameter, and Others), By Application (Respiratory Disease, Cardiology, Trauma & Emergency, and Others), By End-User (Hospital & Clinics and Ambulatory Surgical Centers) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/north-american-capnography-devices-market
Key trends shaping the North American capnography landscape include growing demand for noninvasive, continuous respiratory monitoring, increased deployment in ambulatory surgical centers and prehospital care, and regulatory and reimbursement support aimed at improving patient safety outcomes. The market also benefits from heightened awareness of early respiratory compromise detection, particularly in post-operative and opioid-treated patients.
According to the U.S. Centers for Disease Control and Prevention (CDC), respiratory diseases remain a significant public health concern in the United States, with millions of adults affected by chronic respiratory conditions that often require continuous breathing and ventilation monitoring. These health burdens contribute to the clinical need for advanced respiratory monitoring technologies such as capnography devices.
Key Innovators Driving North America Capnography Devices Transformation
The key players in the North America capnography devices market include Becton, Dickinson and Company, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, among others. These companies are advancing the market through innovations in high-accuracy EtCO? measurement, portable and wearable form factors, and integrated multiparameter monitoring platforms, reinforcing capnography’s role as a standard of care across acute and critical healthcare settings.
Market Coverage
Key questions addressed by the report.
North America Capnography Devices Market Report Segment
By Product Type
By Application
By End-User
North America Capnography Devices Market Report Segment by Country
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-capnography-devices-market